An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself

NYU Langone Medical Center, New York

Memorial Sloan Kettering Cancer Center, New York

Roswell Park Cancer Institute, Buffalo

University of Pittsburgh Medical Center, Pittsburgh

St Luke's Health Network, Easton

Lehigh Valley Health Network, Allentown

Abramson Cancer Center of The University of Pennsylvania, Philadelphia

Washington Cancer Inst at MedStar Washington Hospital Ctr, Washington D.C.

Weinberg Cancer Institute At Franklin Square, Washington D.C.

Georgetown University Medical Center, Washington D.C.

University of North Carolina at Chapel Hill, Chapel Hill

Duke University Medical Center, Durham

Mount Sinai Medical Center, Miami Beach

The Cleveland Clinic Foundation, Weston

H Lee Moffitt Cancer Center and Research Institute, Tampa

Vanderbilt University Medical Center, Nashville

University of Michigan Comprehensive Cancer Center, Ann Arbor

Karmanos Cancer Institute, Detroit

Inova Melanoma and Skin Cancer Center, Fairfax

Loyola University Medical Center, Maywood

University of Chicago, Chicago

MD Anderson Cancer Center, Houston

University of Colorado - Cancer Center - PPDS, Aurora

University of Utah - Huntsman Cancer Institute - PPDS, Salt Lake City

Angeles Clinic and Research Institute, Los Angeles

UCLA Medical Hematology and Oncology, Los Angeles

City of Hope, Duarte

The California Pacific Medical Research Institute, San Francisco

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

Stanford University, Palo Alto

Winship Cancer Institute, Emory University, Atlanta

Dana Farber Cancer Institute., Boston

Dana Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston

Cancer Institute of New Jersey, New Brunswick

Case School of Medicine University Hospitals of Cleveland, Cleveland